Monday, January 11, 2016

Weekly Links January 11th, 2016



“MUST READ”
    • Today, we’re at a stage in the advance of genomic sequencing technologies that has me feeling like it’s 1994 all over again.
Just as only a small percentage of people in the early 1990s had a smartphone, only a small percentage of people today have had their genome sequenced. The healthcare industry is only seeing the beginning of the insights that can be obtained with genomic data.
A wave of innovation waits to be unleashed. But first, standards are needed.
    • In the past year or so, researchers have discovered that the bacterial system can be harnessed to make precise changes to the DNA of humans, as well as other animals and plants.
    • Already the molecular system, known as Crispr, is being used to make genetically engineered laboratory animals more easily than could be done before, with changes in multiple genes. Scientists in China recently made monkeys with changes in two genes.
DISRUPTION, REVOLUTION
    • The medical and life sciences stand on the threshold of an era that will usher in a more in-depth understanding of biological and disease processes at a molecular level, made possible by synthetic biology. The practical applications of this new capability will have profound positive effects on healthcare, the environment, and the economy.
TOOLS/TECHNIQUES
Library construction for next-generation sequencing: Overviews and challenges High-throughput sequencing, also known as next-generation sequencing (NGS), has revolutionized genomic research. In recent years, NGS technology has steadily improved, wit…
HEALTH/MEDECINE
    • Most businesses know the cost of everything that goes into producing what they sell — essential information for setting prices. Medicine is different. Hospitals know what they are paid by insurers, but it bears little relationship to their costs
    • But now, thanks to a project Dr. Lee set in motion after that initial query several years ago, the hospital is getting answers, information that is not only saving money but also improving care.

COMPANIES
Thermo Fisher (TMO) to Acquire Affymetrix (AFFX) for $14/Share Thermo Fisher Scientific Inc. (NYSE: TMO) and Affymetrix Inc. (NASDAQ: AFFX) announced that their boards of directors have unanimously approved Thermo Fisher’s acquisition of Affymetrix
    • Stilla Technologies focuses on accelerating the development of next-generation genetic tests by providing biologists with its Naica platform, a groundbreaking tool for high-resolution genetic analysis.
The Naica platform implements Crystal Digital PCR, or Crystal dPCR, the fastest technology for reliable precision genetic analysis.
SOMETHING DIFFERENT
        www.nytimes.com
The Lawyer Who Became DuPont’s Worst Nightmare Just months before Rob Bilott made partner at Taft Stettinius & Hollister, he received a call on his direct line from a cattle farmer. The farmer, Wilbur Tennant of Parkersburg, W.Va., said that his cow…



No comments:

Post a Comment